Stockscreener 앱 받기
3.51
0.43%
0.010
전일 마감가:
$3.50
열려 있는:
$3.52
하루 거래량:
60,428
Relative Volume:
0.16
시가총액:
$278.55M
수익:
$351.37M
순이익/손실:
$-174.01M
주가수익비율:
-1.6957
EPS:
-2.07
순현금흐름:
$-126.94M
1주 성능:
+0.72%
1개월 성능:
+2.48%
6개월 성능:
+13.75%
1년 성능:
-7.98%
1일 변동 폭
$3.45
$3.545
1주일 범위
$3.41
$3.60
52주 변동 폭
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
명칭
Atea Pharmaceuticals Inc
전화
857-204-8109
주소
225 FRANKLIN STREET, BOSTON
AVIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.51 | 280.13M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.70 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.36 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.26 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
665.65 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
311.21 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | 개시 | Evercore ISI | Outperform |
| 2020-11-24 | 개시 | JP Morgan | Overweight |
| 2020-11-24 | 개시 | Morgan Stanley | Overweight |
| 2020-11-24 | 개시 | William Blair | Outperform |
모두보기
Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스
Can volume confirm reversal in Atea Pharmaceuticals Inc.July 2025 Patterns & Verified Chart Pattern Trade Signals - Newser
Is It Too Early to Call Recovery in Atea Pharmaceuticals Inc.2025 Trading Volume Trends & High Return Trade Opportunity Guides - newsyoung.net
Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersEarnings Miss & Long-Term Growth Stock Strategies - Newser
Predicting Atea Pharmaceuticals Inc. trend using moving averagesJuly 2025 Earnings & Entry and Exit Point Strategies - Newser
Intraday pattern recognizer results for Atea Pharmaceuticals Inc.Options Play & Verified Swing Trading Watchlist - Newser
Volatility clustering patterns for Atea Pharmaceuticals Inc.July 2025 Volume & Growth Focused Stock Reports - Newser
Analyzing net buyer seller activity in Atea Pharmaceuticals Inc.Earnings Recap Summary & Consistent Return Investment Signals - Newser
Atea Pharmaceuticals Inc. stock daily chart insightsQuarterly Risk Review & Weekly Stock Breakout Alerts - Newser
Regression analysis insights on Atea Pharmaceuticals Inc. performanceForecast Cut & Free Technical Pattern Based Buy Signals - Newser
Multi factor analysis applied to Atea Pharmaceuticals Inc.New Guidance & Safe Entry Point Alerts - Newser
Atea Pharmaceuticals Inc. stock momentum explainedJuly 2025 Levels & Low Risk Entry Point Guides - Newser
Using data filters to optimize entry into Atea Pharmaceuticals Inc.Weekly Trading Summary & AI Forecast Swing Trade Picks - Newser
Is Atea Pharmaceuticals Inc. trending in predictive chart modelsMarket Activity Report & Real-Time Chart Breakout Alerts - Newser
Developing predictive dashboards with Atea Pharmaceuticals Inc. dataWeekly Trend Report & Fast Moving Market Watchlists - Newser
Order flow analysis tools used on Atea Pharmaceuticals Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Technical signs of recovery in Atea Pharmaceuticals Inc.Watch List & Target Return Focused Picks - Newser
What the charts say about Atea Pharmaceuticals Inc. today2025 Short Interest & Fast Gaining Stock Reports - Newser
Published on: 2025-08-19 01:45:06 - Newser
Atea Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayPortfolio Performance Summary & Fast Moving Stock Trade Plans - Newser
Using data tools to time your Atea Pharmaceuticals Inc. exit2025 Big Picture & Breakout Confirmation Trade Signals - Newser
How to build a custom watchlist for Atea Pharmaceuticals Inc.July 2025 Volume & Weekly Market Pulse Alerts - Newser
Will breakout in Atea Pharmaceuticals Inc. lead to full recoveryWeekly Trade Report & Weekly High Potential Stock Alerts - Newser
Visualizing Atea Pharmaceuticals Inc. stock with heatmapsQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - Newser
Atea Pharmaceuticals Inc. stock volume spike explainedWeekly Stock Report & Safe Swing Trade Setups - Newser
What earnings revisions data tells us about Atea Pharmaceuticals Inc.July 2025 Closing Moves & Target Return Focused Stock Picks - Newser
How institutional ownership impacts Atea Pharmaceuticals Inc. stockTrade Risk Summary & High Accuracy Trade Alerts - Newser
What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundJuly 2025 Summary & Risk Managed Investment Signals - Newser
Will Atea Pharmaceuticals Inc. price bounce be sustainableExit Point & Pattern Based Trade Signal System - Newser
Published on: 2025-08-17 06:07:26 - metal.it
Institutional scanner results for Atea Pharmaceuticals Inc.Weekly Profit Report & Free Daily Entry Point Trade Alerts - Newser
What candlestick patterns are forming on Atea Pharmaceuticals Inc.Breakout Watch & Real-Time Chart Pattern Alerts - Newser
Is Atea Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser
Atea Pharmaceuticals’ Earnings Call Highlights HCV Progress - MSN
What makes Atea Pharmaceuticals Inc. stock price move sharply2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
Quantitative breakdown of Atea Pharmaceuticals Inc. recent moveProfit Target & Free High Return Stock Watch Alerts - Newser
Atea Pharmaceuticals Inc (AVIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Atea Pharmaceuticals Inc 주식 (AVIR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
1.13%
0.26%
자본화:
|
볼륨(24시간):